A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00356681
Recruitment Status : Terminated (Sponsor decision to close study)
First Posted : July 26, 2006
Last Update Posted : October 15, 2015
Information provided by (Responsible Party):